News from Par Pharmaceutical, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jul 09, 2014, 08:00 ET Par Pharmaceutical Begins Shipment of Fluphenazine Decanoate Injection, USP

Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the U.S. Food and Drug Administration for its...


Jan 21, 2014, 07:00 ET Par Pharmaceutical to Acquire JHP Pharmaceuticals

 Par Pharmaceutical Companies, Inc. ("Par") today announced  that it has entered into a definitive agreement to acquire JHP Group...


Nov 20, 2013, 09:00 ET Par Pharmaceutical Begins Shipment of Generic Focalin XR® Capsules

 Par Pharmaceutical Companies, Inc. today announced that it has begun shipping dexmethylphenidate hydrochloride (HCl) 15 mg and 30 mg...


May 08, 2013, 12:09 ET Par Pharmaceutical Announces Quarterly Conference Call

 Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Thursday, May 16, 2013, at 10:00 a.m. EDT to review...


Oct 25, 2012, 10:01 ET Par Pharmaceutical Receives Final Approval To Market Tretinoin Capsules

 Par Pharmaceutical Companies, Inc. today announced that its operating subsidiary, Anchen Pharmaceuticals, Inc., has received final approval...


Sep 28, 2012, 11:40 ET Par Announces Completion Of Acquisition By TPG

 Par Pharmaceutical Companies, Inc., and TPG today announced the completion of Par's acquisition by certain affiliates of TPG. "This...


Apr 09, 2012, 09:00 ET Par Pharmaceutical Companies to Report First Quarter 2012 Results on May 8, 2012

 Par Pharmaceutical Companies, Inc. (NYSE: PRX) announced today that it will host a conference call and live webcast on Tuesday, May 8, 2012 at...


Apr 06, 2012, 07:30 ET Par Pharmaceutical Begins Shipment of Generic Provigil®

Par Pharmaceutical Companies, Inc. (NYSE:PRX) today announced that it began shipping all strengths of modafinil tablets, a generic version of...


Nov 17, 2011, 12:45 ET Par Pharmaceutical Completes Acquisition of Anchen

Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it has completed its acquisition of Anchen Pharmaceuticals, a privately-held...


Oct 14, 2011, 16:15 ET Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES

Par Pharmaceutical, Inc., the wholly-owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it filed a declaratory...


Aug 24, 2011, 07:00 ET Par Pharmaceutical To Acquire Anchen Pharmaceuticals

Par Pharmaceutical Companies, Inc. (NYSE: PRX) announced today that it entered into a definitive agreement to acquire Anchen Pharmaceuticals, a...


May 04, 2010, 07:30 ET Par Pharmaceutical Companies Reports Cash EPS and GAAP EPS of $0.75 for First Quarter 2010

Par Pharmaceutical Companies, Inc. (NYSE: PRX) today reported results for the first quarter ended March 31, 2010. For the first quarter ended...


Feb 05, 2010, 16:45 ET Strativa Pharmaceuticals Provides An Update On Zuplenz(R) (Ondansetron) Oral Soluble Film

Strativa Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the new drug...


Apr 01, 2009, 08:00 ET Strativa Pharmaceuticals Acquires Worldwide Rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray From QOL Medical

First and Only Once-weekly, Self-administered Alternative to Injections for Treatment of Vitamin B12 Deficiency Strativa Pharmaceuticals, the...


Feb 25, 2008, 00:00 ET Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine

WOODCLIFF LAKE, N.J., Feb. 25 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary...


Jan 15, 2008, 00:00 ET Strativa Pharmaceuticals Acquires Commercialization Rights to Onconase(R) from Alfacell Corporation

WOODCLIFF LAKE, N.J., Jan. 15 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary...


May 04, 2004, 01:00 ET Par Pharmaceutical Begins Shipment of Generic Glucovance(R) Tablets

SPRING VALLEY, N.Y., May 4 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., the principal subsidiary of Pharmaceutical Resources, Inc. (NYSE:...


Feb 12, 2004, 00:00 ET Par Pharmaceutical to Market Generic Purinethol(R) Tablets

SPRING VALLEY, N.Y., Feb. 12 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., the principal subsidiary of Pharmaceutical Resources, Inc....


Nov 28, 2003, 00:00 ET Par Pharmaceutical to Begin Shipment of Metformin Hydrochloride Extended-Release Tablets

SPRING VALLEY, N.Y., Nov. 28 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., the principal subsidiary of Pharmaceutical Resources, Inc....


Nov 06, 2003, 00:00 ET Par Pharmaceutical Announces Joint Development Agreement With Glatt

SPRING VALLEY, N.Y., Nov. 6 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., the principal subsidiary of Pharmaceutical Resources, Inc. (NYSE:...


Sep 16, 2003, 01:00 ET Par Pharmaceutical Begins Shipment of Nefazodone Hydrochloride Tablets

SPRING VALLEY, N.Y., Sept. 16 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., the principal subsidiary of Pharmaceutical Resources, Inc....


Sep 02, 2003, 01:00 ET Par Pharmaceutical Announces Agreement With Bristol-Myers Squibb for Megace(R)

SPRING VALLEY, N.Y., Sept. 2 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., the principal subsidiary of Pharmaceutical Resources, Inc....


Jul 07, 2003, 01:00 ET Par Pharmaceutical Announces Licensing Agreement With Paddock Laboratories

SPRING VALLEY, N.Y., July 7 /PRNewswire-FirstCall/ - Pharmaceutical Resources, Inc. (NYSE: PRX) announced today that through its subsidiary, Par...


Oct 21, 2002, 01:00 ET Par Pharmaceutical Announces Filing Of Tramadol Hydrochloride Tablets With Acetaminophen

SPRING VALLEY, N.Y., Oct. 21 /PRNewswire-FirstCall/ -- Par Pharmaceutical, Inc., a subsidiary of Pharmaceutical Resources, Inc. (NYSE: PRX),...


Jan 29, 2002, 00:00 ET Par Pharmaceutical Announces Approvable Status of ANDA For Tramadol HCl Tablets

SPRING VALLEY, N.Y., Jan. 29 /PRNewswire-FirstCall/ -- Par Pharmaceutical, a subsidiary of Pharmaceutical Resources, Inc. (NYSE: PRX), announced...